Management Strategies for Antidepressant-Related Sexual Dysfunction: A Clinical Approach

Pycnogenol supplementation as an adjunct treatment for antidepressant-induced sexual dysfunction

(2019) A Smetanka et al.   Physiology International

Clinical implications of directly switching antidepressants in well-treated depressed patients with treatment-emergent sexual dysfunction: a comparison between vortioxetine and escitalopram

(2019) Paula L. Jacobsen et al.   CNS SPECTRUMS

Frequency of Sexual Dysfunction in Patients Treated with Desvenlafaxine: A Prospective Naturalistic Study

(2019) Angel L. Montejo et al.   Journal of Clinical Medicine

The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management

(2018) Angel L. Montejo et al.   World Psychiatry

Effect of sildenafil on the activity of some antidepressant drugs and electroconvulsive shock treatment in the forced swim test in mice

(2016) Katarzyna Socała et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

An Integrated Analysis of the Safety and Tolerability of Desvenlafaxine Compared with Placebo in the Treatment of Major Depressive Disorder

(2016) Anita H. Clayton et al.   CNS SPECTRUMS

Searching for answers and validation: Australian women’s experiences of coping with the adverse sexual effects of antidepressants

(2015) Cathy O'Mullan et al.   Australian Journal of Primary Health

Impact of Antidepressant Drugs on Sexual Function and Satisfaction

(2015) David S. Baldwin et al.   CNS DRUGS

Antidepressant-induced sexual dysfunction during treatment with fluoxetine, sertraline and trazodone; a randomized controlled trial

(2015) Habibolah Khazaie et al.   GENERAL HOSPITAL PSYCHIATRY

Effects of 50 and 100 mg desvenlafaxine versus placebo on sexual function in patients with major depressive disorder

(2015) Anita H. Clayton et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Vortioxetine in Adults With Major Depressive Disorder

(2015) Atul R. Mahableshwarkar et al.   JOURNAL OF CLINICAL PSYCHIATRY

Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale

(2015) Angel L Montejo et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction

(2015) Paula L. Jacobsen et al.   Journal of Sexual Medicine

Desvenlafaxine 50 and 100 mg/d Versus Placebo for the Treatment of Major Depressive Disorder

(2014) Anita H. Clayton et al.   JOURNAL OF CLINICAL PSYCHIATRY

Sildenafil, a phosphodiesterase type 5 inhibitor, reduces antidepressant-like activity of paroxetine in the forced swim test in mice

(2014) Katarzyna Socała et al.   Pharmacological Reports

Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals

(2014) Andrew A. Crawford et al.   PSYCHOPHARMACOLOGY

Comparative Benefits and Harms of Second-Generation Antidepressants for Treating Major Depressive Disorder

(2013) Gerald Gartlehner et al.   ANNALS OF INTERNAL MEDICINE

Discussing sexual function in the cardiology practice

(2013) M. P. J. Nicolai et al.   Clinical Research in Cardiology

Sexual Dysfunction associated with Second-Generation Antidepressants in Patients with Major Depressive Disorder: Results from a Systematic Review with Network Meta-Analysis

(2013) Ursula Reichenpfader et al.   DRUG SAFETY

Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder

(2013) Mohammed Y. Alam et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Attitudes and Behavior of Radiation Oncologists Toward Sexual Issues of Cervical Cancer Patients Who Receive Radiation Therapy

(2013) Jin Wang et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Management strategies for SSRIinduced sexual dysfunction

(2013) Sakina Rizvi et al.   JOURNAL OF PSYCHIATRY & NEUROSCIENCE

Surrogate Partner Therapy: Ethical Considerations in Sexual Medicine

(2013) Talli Rosenbaum et al.   Journal of Sexual Medicine

Bidirectional Association Between Depression and Sexual Dysfunction: A Systematic Review and Meta-Analysis

(2012) Evan Atlantis et al.   Journal of Sexual Medicine

An Evaluation of Sexual Functioning in Employed Outpatients with Major Depressive Disorder Treated with Desvenlafaxine 50mg or Placebo

(2012) Anita H. Clayton et al.   Journal of Sexual Medicine

Influence of sildenafil on the antidepressant activity of bupropion and venlafaxine in the forced swim test in mice

(2012) Katarzyna Socała et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Sildenafil, a phosphodiesterase type 5 inhibitor, enhances the activity of two atypical antidepressant drugs, mianserin and tianeptine, in the forced swim test in mice

(2012) Katarzyna Socała et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

The effects of agomelatine on sexual function in depressed patients and healthy volunteers

(2011) Angel Montejo et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Frequency of treatment-emergent sexual dysfunction and treatment effectiveness during SSRI or duloxetine therapy: 8-week data from a 6-month observational study

(2011) Hector Dueñas et al.   INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE

Treatment-emergent sexual dysfunction with SSRIs and duloxetine: Effectiveness and functional outcomes over a 6-month observational period

(2011) Héctor Dueñas et al.   INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE

Neural Correlates of Antidepressant-Related Sexual Dysfunction: A Placebo-Controlled fMRI Study on Healthy Males Under Subchronic Paroxetine and Bupropion

(2011) Birgit Abler et al.   NEUROPSYCHOPHARMACOLOGY

Antidepressant-Induced Sexual Dysfunction among Newer Antidepressants in a Naturalistic Setting

(2010) Kyoung-Uk Lee et al.   Psychiatry Investigation

Sexual Side-Effects of Contemporary Antidepressants: Review

(2009) Isaac Schweitzer et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Differences in Adverse Effect Reporting in Placebo Groups in SSRI and Tricyclic Antidepressant Trials

(2009) Winfried Rief et al.   DRUG SAFETY

Treatment-Emergent Sexual Dysfunction Related to Antidepressants

(2009) Alessandro Serretti et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Prevalence and impact of antidepressant-associated sexual dysfunction in three European countries: replication in a cross-sectional patient survey

(2009) VSL Williams et al.   JOURNAL OF PSYCHOPHARMACOLOGY

ORIGINAL RESEARCH–EPIDEMIOLOGY: Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction

(2009) Giovanni Corona et al.   Journal of Sexual Medicine

A Double-Blind Comparison of Sexual Functioning, Antidepressant Efficacy, and Tolerability Between Agomelatine and Venlafaxine XR

(2008) Sidney H. Kennedy et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Review: Problems associated with long-term treatment with selective serotonin reuptake inhibitors

(2008) C. Moret et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale

(2008) AL Montejo et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Review: Bupropion and SSRI-induced side effects

(2008) K. Demyttenaere et al.   JOURNAL OF PSYCHOPHARMACOLOGY